JP2022546550A5 - - Google Patents
Info
- Publication number
- JP2022546550A5 JP2022546550A5 JP2022514172A JP2022514172A JP2022546550A5 JP 2022546550 A5 JP2022546550 A5 JP 2022546550A5 JP 2022514172 A JP2022514172 A JP 2022514172A JP 2022514172 A JP2022514172 A JP 2022514172A JP 2022546550 A5 JP2022546550 A5 JP 2022546550A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- subject
- cbs
- thcy
- level
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025130469A JP2025183204A (ja) | 2019-09-03 | 2025-08-05 | 上昇したホモシステインレベルを処置するためのシスタチオニンベータ合成酵素による酵素療法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962895230P | 2019-09-03 | 2019-09-03 | |
| US62/895,230 | 2019-09-03 | ||
| US202062983862P | 2020-03-02 | 2020-03-02 | |
| US62/983,862 | 2020-03-02 | ||
| PCT/US2020/049156 WO2021046190A1 (en) | 2019-09-03 | 2020-09-03 | Cystathionine beta-synthase enzyme therapy for treatment of elevated homocysteine levels |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025130469A Division JP2025183204A (ja) | 2019-09-03 | 2025-08-05 | 上昇したホモシステインレベルを処置するためのシスタチオニンベータ合成酵素による酵素療法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022546550A JP2022546550A (ja) | 2022-11-04 |
| JP2022546550A5 true JP2022546550A5 (https=) | 2023-09-07 |
Family
ID=74852233
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022514172A Pending JP2022546550A (ja) | 2019-09-03 | 2020-09-03 | 上昇したホモシステインレベルを処置するためのシスタチオニンベータ合成酵素による酵素療法 |
| JP2025130469A Pending JP2025183204A (ja) | 2019-09-03 | 2025-08-05 | 上昇したホモシステインレベルを処置するためのシスタチオニンベータ合成酵素による酵素療法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025130469A Pending JP2025183204A (ja) | 2019-09-03 | 2025-08-05 | 上昇したホモシステインレベルを処置するためのシスタチオニンベータ合成酵素による酵素療法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220290116A1 (https=) |
| EP (1) | EP4025243A4 (https=) |
| JP (2) | JP2022546550A (https=) |
| KR (1) | KR20220091464A (https=) |
| CN (1) | CN114630673A (https=) |
| AU (1) | AU2020343314A1 (https=) |
| BR (1) | BR112022003539A2 (https=) |
| CA (1) | CA3152379A1 (https=) |
| IL (1) | IL290685A (https=) |
| MX (1) | MX2022002571A (https=) |
| WO (1) | WO2021046190A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI3998067T3 (fi) | 2015-11-09 | 2024-10-31 | Univ Colorado Regents | Koostumukset ja menetelmät homokystinurian hoitoon |
| IL269544B2 (en) | 2017-04-17 | 2025-01-01 | Univ Colorado Regents | Streamlining enzyme replacement therapy for the treatment of high homocysteine |
| ES3058596T3 (en) * | 2019-06-26 | 2026-03-11 | Travere Therapeutics Switzerland Gmbh | Pegylated cystathionine beta synthase for enzyme therapy for treatment of homocystinuria |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9034318B2 (en) * | 2011-08-30 | 2015-05-19 | The Regents Of The University Of Colorado, A Body Corporate | Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria |
| US9675678B2 (en) * | 2013-01-29 | 2017-06-13 | The Regents Of The University Of Colorado, A Body Corporate | Compositions and methods for treatment of homocystinuria |
| FI3998067T3 (fi) * | 2015-11-09 | 2024-10-31 | Univ Colorado Regents | Koostumukset ja menetelmät homokystinurian hoitoon |
| IL269544B2 (en) * | 2017-04-17 | 2025-01-01 | Univ Colorado Regents | Streamlining enzyme replacement therapy for the treatment of high homocysteine |
| ES3058596T3 (en) * | 2019-06-26 | 2026-03-11 | Travere Therapeutics Switzerland Gmbh | Pegylated cystathionine beta synthase for enzyme therapy for treatment of homocystinuria |
-
2020
- 2020-09-03 CA CA3152379A patent/CA3152379A1/en active Pending
- 2020-09-03 BR BR112022003539A patent/BR112022003539A2/pt unknown
- 2020-09-03 AU AU2020343314A patent/AU2020343314A1/en active Pending
- 2020-09-03 US US17/639,509 patent/US20220290116A1/en active Pending
- 2020-09-03 KR KR1020227011039A patent/KR20220091464A/ko active Pending
- 2020-09-03 EP EP20861108.7A patent/EP4025243A4/en active Pending
- 2020-09-03 MX MX2022002571A patent/MX2022002571A/es unknown
- 2020-09-03 WO PCT/US2020/049156 patent/WO2021046190A1/en not_active Ceased
- 2020-09-03 JP JP2022514172A patent/JP2022546550A/ja active Pending
- 2020-09-03 CN CN202080076522.3A patent/CN114630673A/zh active Pending
-
2022
- 2022-02-17 IL IL290685A patent/IL290685A/en unknown
-
2025
- 2025-08-05 JP JP2025130469A patent/JP2025183204A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12558324B2 (en) | Application of R-ketamine and salt thereof as pharmaceuticals | |
| JP5363152B2 (ja) | グリシン捕捉性アンタゴニストを用いる拒絶性および認知性精神分裂病症候群の処置 | |
| Guaraldi et al. | An open trial of methyltetrahydrofolate in elderly depressed patients | |
| ES2284660T3 (es) | Composicion que contiene un antiofolato y un agente que rebaja el acido metilmalonico. | |
| Sessa et al. | Phase I and pharmacological studies of the cryptophycin analogue LY355703 administered on a single intermittent or weekly schedule | |
| JP2022546550A5 (https=) | ||
| CN111417391B (zh) | 用于抑制肿瘤生长的材料和方法 | |
| JP2018530578A (ja) | 組み合せ抗細菌組成物および短期抗細菌レジメン | |
| JP6966840B2 (ja) | 神経変性疾患の改善用医薬 | |
| Wei et al. | Folate/vitamin-B12 prevents chronic hyperhomocysteinemia-induced tau hyperphosphorylation and memory deficits in aged rats | |
| WO2017151723A1 (en) | Cobalamin compositions and use thereof for improving cognitive function | |
| US10172857B2 (en) | Boosting the effect of methotrexate through the combined use with lipophilic statins | |
| JP2017533967A (ja) | システアミン組成物を用いるハンチントン病の処置方法 | |
| TW202247843A (zh) | 醫藥組合物治療肺癌之用途 | |
| US20230038138A1 (en) | Combination therapy for treating cancer | |
| JP2006508118A5 (https=) | ||
| WO2022028678A1 (en) | Substances for treatment of neurological disorders | |
| JP2024016228A (ja) | アセトアミノフェン（ａｐａｐ）によって引き起こされる毒性を予防、低減または根絶するための方法および組成物 | |
| Hanauske et al. | Phase Ib safety and pharmacokinetic evaluation of daily and twice daily oral enzastaurin in combination with pemetrexed in advanced/metastatic cancer | |
| CN1134670A (zh) | 亚甲兰用于治疗或预防异环磷酰胺引起的脑病 | |
| CN115175678A (zh) | 使用btk抑制剂及其组合治疗dlbcl的方法 | |
| KR20220024434A (ko) | 신경퇴행성 장애를 치료하는 방법 | |
| JP2007523827A (ja) | 混合性白血病遺伝子の再構成を伴う急性リンパ芽球性白血病の処置方法 | |
| Kanwar et al. | The Method and Results of a Treatment Targeting SARS-CoV-2-Activated In ammasomes | |
| TW202519221A (zh) | Ｗｅｅ１抑制劑及ｐｋｍｙｔ１抑制劑之組合 |